期刊文献+

基于微透析-UPLC技术的异嗪皮啶大鼠脑纹状体细胞外液药动学研究 被引量:3

Pharmacokinetics of Isofraxidin in Extracellular Fluids of Striatum in Rats Using Microdialysis-UPLC Method
下载PDF
导出
摘要 目的:考察大鼠口服给药异嗪皮啶(Isofraxidin)之后的脑纹状体细胞外液药动学特性。方法:大鼠单次灌胃给予异嗪皮啶10 mg.kg-1和20 mg.kg-1后,采用脑微透析活体取样技术和超高效液相色谱质谱联用技术(UPLC-MS),测定给药后60 min内各时间点大鼠脑纹状体细胞外液中透析液异嗪皮啶的浓度,经回收率校正后,采用WINONLIN 6.1程序以非房室模型法拟合药动学参数。结果:大鼠单次灌胃给予异嗪皮啶10 mg.kg-1和20 mg.kg-1后,其主要药动学参数分别为AUC0-∞(13973.88±1582.984)、(28059.76±4207.66)ng.min.mL-1;t1/2(16.68±0.49)、(17.41±2.88)min;Cmax(498.87±64.36)、(899.81±133.22)ng.mL-1;tmax均为15 min,其中Cmax和tmax均为实测值。结论:异嗪皮啶经大鼠口服给药后能够迅速透过血脑屏障,到达纹状体部位,15 min浓度达到最大值,之后药物以较快速率消除,纹状体细胞外液异嗪皮啶浓度具有明显的剂量依赖性。 This study was aimed to observe the pharmacokinetic characteristics of isofraxidin in extracellular fluids of striatum in rats after oral administration of isofraxidin.Microdialysis and UPLC-MS analytical technology were employed in the study to detect the concentration of isofraxidin in microdialysis dialysate of extracellular fluids of striatum in rats,within 60 min after a single oral administration,with isofraxidin of 10 mg·kg-1 and 20 mg·kg-1,respectively.The results were revised by relative recovery in vivo.The pharmacokinetic parameters were calculated through non-compartment model method with software of WINONLIN 6.1 program.Main pharmacokinetic parameters of isofraxidin in extracellular fluids of striatum in rats after a single oral administration of isofraxidin at 10 mg·kg-1 and 20 mg·kg-1 were AUC0-∞(13973.88±1582.984) and(28059.76±4207.66) ng·min·mL-1;t1/2(16.68±0.49) and(17.41±2.88) min;Cmax(498.87±64.36) and(899.81±133.22) ng·mL-1.The tmax of both two groups was 15 min.Both the Cmax and tmax were measured.It is concluded that isofraxidin quickly permeates the blood-brain barrier and reaches the striatum.The maximal concentration of isofraxidin is 15 min after oral administration.And then the concentration decreases at a faster rate.It shows a significant dose-dependent phenomenon of the concentration of isofraxidin in extracellular fluids of striatum in rats.
出处 《世界科学技术-中医药现代化》 北大核心 2012年第1期1206-1210,共5页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 国家自然科学基金青年科学基金项目(30901974):刺五加治疗帕金森病有效成分的药动学及药物代谢轮廓研究,负责人:卢芳 科学技术部国家“重大新药创制”科技重大专项项目(2009ZX09103):刺五加有效组分优化体治疗帕金森病的成药性研究,负责人:刘树民 教育部“春晖计划”合作科研项目(Y-30):基于微透析-UPLC技术的刺五加治疗PD有效组分脑内药动学研究,负责人:卢芳
关键词 刺五加 异嗪皮啶 微透析 超高效液相色谱-质谱联用 药动学 Acanthopanax senticosus isofraxidin microdialysis UPLC-MS Pharmacokinetics
  • 相关文献

参考文献7

二级参考文献82

共引文献110

同被引文献63

  • 1赵喜林,顾振纶,秦正红.长期低剂量皮下注射鱼藤酮制作大鼠帕金森病模型[J].中国药理学通报,2005,21(10):1274-1277. 被引量:27
  • 2李范珠,冯健.脑微透析技术及其在脑内药动学中的应用[J].中国药学杂志,2006,41(6):405-407. 被引量:16
  • 3张琳,刘树民.刺五加防治帕金森病研究进展[J].中国中医药信息杂志,2007,14(3):95-96. 被引量:7
  • 4诸葛启钏.大鼠脑立体定位图谱(第3版).北京:人民卫生出版社,2005∶82.
  • 5国家药典委员会.中国药典(2010年版).北京:中国医药科技出版社,2010:192.
  • 6Baqqer MA, Bechqaard E. The potential of nasal application for de- livery to the central brain-a microdialysis study of fluorescein in rats. Eur J Pharm Sci, 2004, 21(2):235-242.
  • 7Hirsch EC, Hunot S, Damier P, et ol. Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration. Ann Neurol, 1998, (3):Sl15-S120.
  • 8Faucheux BA, Bonnet AM, Agid Y, et al. Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet, 1999, 353(9157):981-982.
  • 9Tada Oikawa S, Hiraku Y, Kawanishi M, et al. Mechanism for gen- eration of hydrogen peroxide and change of mitochondrial membrane potential during rotenone-induced apoptosis. Life Sciences, 2003,73 (25):3277-3288.
  • 10Bashkatova V, Alam M, Vanin A, et al. Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain. Experimental Neurology, 2004, 186 (2): 235-241.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部